Kinnate Biopharma Future Growth
How is Kinnate Biopharma forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
0.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 24 | -194 | -169 | -209 | 4 |
| 12/31/2024 | N/A | -184 | -144 | -172 | 5 |
| 12/31/2023 | N/A | -150 | -121 | -138 | 7 |
| 9/30/2022 | N/A | -111 | -91 | -88 | N/A |
| 6/30/2022 | N/A | -105 | -88 | -85 | N/A |
| 3/31/2022 | N/A | -99 | -81 | -79 | N/A |
| 12/31/2021 | N/A | -90 | -72 | -71 | N/A |
| 9/30/2021 | N/A | -77 | -62 | -62 | N/A |
| 6/30/2021 | N/A | -63 | -53 | -53 | N/A |
| 3/31/2021 | N/A | -49 | -41 | -41 | N/A |
| 12/31/2020 | N/A | -36 | -30 | -30 | N/A |
| 9/30/2020 | N/A | -26 | -20 | -20 | N/A |
| 12/31/2019 | N/A | -10 | -11 | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KNTE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KNTE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KNTE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KNTE is forecast to have no revenue next year.
High Growth Revenue: KNTE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KNTE's Return on Equity is forecast to be high in 3 years time